Location: Palo Alto, CA
CIK: 0001839948 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $679M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GPCR | STRUCTURE THERAPEUTICS INC | 1,502,747 | $75.77M | 11.2% | $44.22 | — | ADRS | 86366E106 |
| COGT | COGENT BIOSCIENCES INC | 5,631,042 | $54.9M | 8.1% | $9.54 | +24.3% | COMM | 19240Q201 |
| GERN | GERON CORP | 23,375,839 | $49.56M | 7.3% | $1.89 | +43.9% | COMM | 374163103 |
| ANTX | AN2 Therapeutics, Inc. | 2,678,209 | $43.07M | 6.3% | $9.33 | +21.3% | COMM | 037326105 |
| SVRA | SAVARA INC. | 10,000,000 | $37.8M | 5.6% | $3.56 | 0.0% | COMM | 805111101 |
| TSHA | TAYSHA GENE THERAPIES, INC. | 11,111,111 | $35.11M | 5.2% | $1.87 | 0.0% | COMM | 877619106 |
| KALV | KALVISTA PHARMACEUTICALS, INC | 3,395,495 | $32.7M | 4.8% | $5.36 | +90.7% | COMM | 483497103 |
| — | INHIBRX,INC | 1,750,387 | $32.12M | 4.7% | $18.35 | — | COMM | 45720L107 |
| — | AEROVATE THERAPEUTICS INC | 2,201,274 | $29.87M | 4.4% | $15.75 | — | COMM | 008064107 |
| — | Icosavax, Inc. | 3,703,704 | $28.7M | 4.2% | $9.93 | — | COMM | 45114M109 |
| CMPS | COMPASS PATHWAYS PLC | 3,858,000 | $28.55M | 4.2% | $7.40 | — | ADRS | 20451W101 |
| VTYX | VENTYX BIOSCIENCES, INC | 815,724 | $28.33M | 4.2% | $29.94 | +15.5% | COMM | 92332V107 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $27.39M | 4.0% | $12.71 | +16.7% | COMM | 90240B106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 179,917 | $26.28M | 3.9% | $110.42 | +70.5% | COMM | 558868105 |
| SLN | SILENCE THERAPEUTICS PLC | 2,104,875 | $20.67M | 3.0% | $10.03 | — | ADRS | 82686Q101 |
| TARS | TARSUS PHARMACEUTICALS, INC. | 1,142,857 | $20.31M | 3.0% | $17.70 | 0.0% | COMM | 87650L103 |
| — | RAYZEBIO, INC. | 869,908 | $19.31M | 2.8% | $22.20 | — | COMM | 75525N107 |
| DYN | DYNE THERAPEUTICS, INC | 1,650,150 | $14.79M | 2.2% | $12.99 | -17.1% | COMM | 26818M108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,040,816 | $13.2M | 1.9% | $6.47 | — | COMM | 152309100 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $12.98M | 1.9% | $14.54 | -30.2% | COMM | 50127T109 |
| IMVT | IMMUNOVANT, INC | 334,853 | $12.86M | 1.9% | $12.59 | +79.5% | COMM | 45258J102 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $9.242M | 1.4% | $17.12 | — | COMM | 29384C108 |
| — | GRACELL BIOTECHNOLOGIES INC. | 3,038,889 | $8.752M | 1.3% | $2.88 | — | ADRS | 38406L103 |
| CABA | CABALETTA BIO, INC | 486,795 | $7.409M | 1.1% | $3.64 | +275.3% | COMM | 12674W109 |
| — | MERUS N.V. | 300,000 | $7.074M | 1.0% | $30.46 | — | COMM | N5749R100 |
| CCCC | C4 THERAPEUTICS, INC. | 1,276,574 | $2.374M | 0.3% | $5.83 | -47.7% | COMM | 12529R107 |